Related content

Optimizing Administration of Bisphosphonates in Women with Postmenopausal Osteoporosis

By Rackoff Paula J.   Sebba Anthony  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Plasma Leptin Concentrations in Postmenopausal Women with Osteoporosis

By Yilmazi Murat   Keles Isik   Aydin Gülümser   Orkun Sevim   Bayram Merih   Ceylan Sevinc F.   Kisa Üçler   Yetkin Ilhan  

Endocrine Research, Vol. 31, Iss. 2, 2005-04 ,pp. : 133-138

Informa Healthcare

Access to resources Recommend Favorite

The Collagen Ia1 SP1 Polymorphism is Associated With Differences in Ultrasound Transmission Velocity in the Calcaneus in Postmenopausal Women

By Kann P.   Bergink A.P.   Fang Y.   van Daele P.L.A.   Hofman A.   van Leeuwen J.P.T.M.   Beyer J.   Uitterlinden A.G.   Pols H.A.P.  

Calcified Tissue International, Vol. 70, Iss. 6, 2002-06 ,pp. : 450-456

Springer Publishing Company

Access to resources Recommend Favorite

Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis

By Harrington J. T.  

Calcified Tissue International, Vol. 74, Iss. 2, 2004-04 ,pp. : 129-135

Springer Publishing Company

Access to resources Recommend Favorite

Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis

By Rizzoli René  

Calcified Tissue International, Vol. 89, Iss. 2, 2011-08 ,pp. : 91-104

Springer Publishing Company

Access to resources Recommend Favorite